Prognostic role of CMR in patients presenting with ventricular arrhythmias

JACC: Cardiovascular Imaging

Volumn 6, Issue 3, 2013, Pages 335-344

  Dawson, Dana K ^a   Hawlisch, Karin ^b   Prescott, Gordon ^a   Roussin, Isabelle ^b   Di Pietro, Elisa ^b   Deac, Monica ^b   Wong, Joyce ^b   Frenneaux, Michael P ^a   Pennell, Dudley J ^b   Prasad, Sanjay K ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

cardiac magnetic resonance; fibrosis; late gadolinium enhancement; nonsustained ventricular tachycardia; ventricular tachycardia

Indexed keywords

GADOBUTROL;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HEART ARREST; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONSUSTAINED VENTRICULAR TACHYCARDIA; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUSTAINED VENTRICULAR TACHYCARDIA;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; FIBROSIS; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SYSTOLE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84875382698     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.09.012     Document Type: Article

References (33)

1. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
2. K.H. Kuck, R. Cappato, J. Siebels, R. Ruppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
3. S.J. Connolly, M. Gent, R.S. Roberts Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
5. A.J. Moss, H. Greenberg, R.B. Case Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
6. M.J. Domanski, S. Sakseena, A.E. Epstein Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias J Am Coll Cardiol 34 1999 1090 1095
7. A.P. Hallstrom, J.H. McAnulty, B.L. Wilkoff Patients at lower risk of arrhythmia recurrence: A subgroup in whom implantable defibrillators may not offer benefit J Am Coll Cardiol 37 2001 1093 1099
8. K. Soejima, W.G. Stevenson, J.L. Sapp, A.P. Selwyn, G. Couper, L.M. Epstein Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: The importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842
9. D. Bello, D.S. Fieno, R.J. Kim Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 2005 1104 1108
10. R.J. Kim, D.S. Fieno, T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
11. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
12. R.Y. Kwong, A.K. Chan, K.A. Brown Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
13. H. Yokota, S. Heidary, C.K. Katikireddy Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy J Cardiovasc Magn Reson 10 2008 17
14. B.Y.C. Cheong, R. Muthupillai, J.M. Wilson Prognostic significance of delayed-enhancement magnetic resonance imaging Circulation 120 2009 2069 2076
15. R.G. Assomull, S.K. Prasad, J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
16. R.Y. Kwong, H. Sattar, H. Wu Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
17. S. Leonardi, C. Raineri, G.M. De Ferrari Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy Eur Heart J 30 2009 2003 2010
18. R. Rubinshtein, J.F. Glockner, S.R. Ommen Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
19. A.S. Adabag, B.J. Maron, E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
20. R. O'Hanlon, A. Grasso, M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
21. K.C. Wu, R.G. Weiss, D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
22. S.D. Roes, C.J.W. Borleffs, R.J. van der Geest Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator Circ Cardiovasc Imaging 2 2009 183 190
23. S. Heidary, H. Patel, J. Chung Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events J Am Coll Cardiol 55 2010 2762 2768
24. L. Iles, H. Pfluger, L. Lefkovits Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
25. S. Nazarian, D.A. Bluemke, A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
26. F.M. Bogun, B. Desjardins, E. Good Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate J Am Coll Cardiol 53 2009 1138 1145
27. A.M. Maceira, S.K. Prasad, M. Khan, D.J. Pennell Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 8 2006 417 426
28. M.A. Wood, B.S. Stambler, R.J. Damiano, P. Greenway, K.A. Ellenbogen Guardian ATP 4210 Multicenter Investigators Group Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator J Am Coll Cardiol 24 1994 1692 1699
29. K. Mahesh, B. Parmar, D. Machin Cox's proportional hazards model D. Machin, Y.B. Cheung, M. Parmar, Survival Analysis: A Practical Approach 1995 Wiley Chichester, United Kingdom 138 140
30. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
31. H. Ashikaga, T. Sasano, J. Dong Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia Circ Res 101 2007 939 947
32. D.H. Kwon, N.G. Smedira, E.R. Rodriguez Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: Correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 54 2009 242 249
33. A. Kadish, A. Dyer, J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158